The EMA has approved Penbraya for protection against invasive meningococcal disease and an update of the composition of two ...
The latest strain of the COVID-19 virus, XEC, is circulating across the country. The new variant has been reported in at ...
As you can see below, at the end of June 2024, Pfizer had US$69.9b of debt, up from US$65.7b a year ago. Click the image for ...
Pfizer Inc (NYSE: PFE) presented positive trial data for experimental drug designed for patients suffering from cancer ...
Shares of Pfizer Inc. PFE dropped 0.81% to $29.42 Friday, on what proved to be an all-around mixed trading session for the ...
Amid a parade of regulatory endorsements in Europe, Apellis Pharmaceuticals’ ophthalmology prospect pegcetacoplan has been ...
Pfizer Inc. (NYSE: PFE, "Pfizer") and BioNTech SE (Nasdaq: BNTX, "BioNTech") today announced that the Committee for Medicinal Products for Human Use ...
Secret History on MSN4h
What If a COVID Vaccine Were Available Tomorrow?With COVID cases on the rise in many countries, the race to find an effective vaccine is becoming a more pressing concern ...
Pfizer and BioNTech said on Friday that a committee from the European Medicine Agency recommended marketing authorization for its Omicron adapted vaccine to prevent Covid-19, meaning the vaccine is ...
Este químico de processos ajudou a aumentar a escala de produção de um componente essencial do antiviral para COVID-19 ...
Este químico de procesos contribuyó al escalado de la producción de un componente clave de un antiviral contra COVID-19 ...
Upon authorization by the European Commission, the Omicron KP.2-adapted COVID-19 vaccine will be available for individuals 6 months of age and older Data demonstrate that the Omicron KP.2-adapted ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback